1000 resultados para phase stationnaire
Resumo:
Référence bibliographique : Rol, 58044
Resumo:
Référence bibliographique : Rol, 58046
Resumo:
Référence bibliographique : Rol, 58050
Resumo:
Référence bibliographique : Rol, 58054
Resumo:
Référence bibliographique : Rol, 58055
Resumo:
Référence bibliographique : Rol, 58056
Resumo:
Référence bibliographique : Rol, 58059
Resumo:
Référence bibliographique : Rol, 58060
Resumo:
Référence bibliographique : Rol, 58061
Resumo:
Référence bibliographique : Rol, 58062
Resumo:
Référence bibliographique : Rol, 58063
Resumo:
Référence bibliographique : Rol, 58065
Resumo:
We assessed the safety, tolerability, and immunogenicity of a mixture of three synthetic peptides derived from the Plasmodium vivax circumsporozoite protein formulated in Montanide ISA 720 or Montanide ISA 51. Forty healthy malaria-naive volunteers were allocated to five experimental groups (A-E): four groups (A-D) were immunized intramuscularly with 50 and 100 μg/dose injections of a mixture of N, R, and C peptides formulated in the two different adjuvants at 0, 2, and 4 months and one group was administered placebo. Vaccines were immunogenic, safe, well tolerated, and no serious adverse events related to the vaccine occurred. Seroconversion occurred in > 90% of the vaccines and antibodies recognized the sporozoite protein on immunofluorescent antibody test. Vaccines in Montanide ISA 51 showed a higher sporozoite protein recognition and interferon production. Results encourage further testing of the vaccine protective efficacy.